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We​ ​appreciate​ ​the​ ​effort​ ​of​ ​(Finsterer​ ​et​ ​al​ ​.)​ ​for​ ​writing​ ​a​ ​letter​ ​to​ ​editor​ ​entitled, 
“Hyperthyroidism​ ​and​ ​noncompaction”​ ​on​ ​our​ ​published​ ​article​ ​“Left​ ​ventricular 
noncompaction​ ​diagnosed​ ​following​ ​Graves'​ ​disease.”​ ​On​ ​behalf​ ​of​ ​all​ ​authors,​ ​we 
would​ ​hereby​ ​like​ ​to​ ​bring​ ​forward​ ​the​ ​following​ ​comments. 
 
Isolated​ ​left​ ​ventricular​ ​noncompaction​ ​(LVNC)​ ​is​ ​a​ ​rare​ ​genetic​ ​cardiomyopathy. 
Clinical​ ​manifestations​ ​are​ ​variable;​ ​patients​ ​may​ ​present​ ​with​ ​heart​ ​failure​ ​symptoms, 
arrhythmias,​ ​and​ ​systemic​ ​thromboembolism.​ ​However,​ ​it​ ​can​ ​also​ ​be​ ​asymptomatic. 
When​ ​asymptomatic,​ ​LVNC​ ​can​ ​manifest​ ​later​ ​in​ ​life​ ​after​ ​the​ ​onset​ ​of​ ​another​ ​unrelated 
condition. 
 
We​ ​do​ ​not​ ​agree​ ​with​ ​what​ ​the​ ​author's​ ​mentioned​ ​about​ ​excluding​ ​LVNC​ ​as​ ​a​ ​cause​ ​of 
heart​ ​failure​ ​in​ ​our​ ​article.​ ​As​ ​we​ ​clearly​ ​mentioned​ ​that​ ​LVNC​ ​was​ ​diagnosed​ ​following 
the​ ​exacerbation​ ​in​ ​contractile​ ​dysfunction​ ​triggered​ ​by​ ​Graves'​ ​disease,[sup][1]​ ​in 
patients​ ​with​ ​hyperthyroidism,​ ​heart​ ​failure​ ​may​ ​occur​ ​in​ ​the​ ​absence​ ​of​ ​underlying​ ​heart 
disease.​ ​Most​ ​patients​ ​with​ ​hyperthyroidism​ ​have​ ​a​ ​high​ ​cardiac​ ​output​ ​state​ ​without 
heart​ ​failure​ ​symptoms.​ ​However,​ ​reduced​ ​LV​ ​contractile​ ​reserve​ ​due​ ​to​ ​LVNC​ ​may 
impair​ ​the​ ​ability​ ​to​ ​increase​ ​the​ ​cardiac​ ​output​ ​to​ ​match​ ​the​ ​increase​ ​of​ ​peripheral 
demand.​ ​In​ ​our​ ​case,​ ​we​ ​think​ ​that​ ​Graves'​ ​disease-induced​ ​hyperthyroidism​ ​led​ ​to​ ​a 
remarkable​ ​increase​ ​in​ ​preload​ ​and​ ​heart​ ​rate​ ​resulting​ ​in​ ​precipitation​ ​of​ ​heart 
failure.[sup][2]​ ​Literature​ ​review​ ​reveals​ ​that​ ​many​ ​patients​ ​with​ ​LVNC​ ​are​ ​minimally 
symptomatic​ ​or​ ​totally​ ​asymptomatic​ ​with​ ​many​ ​patients​ ​diagnosed​ ​with​ ​LVNC​ ​as​ ​an 
incidental​ ​finding​ ​on​ ​echocardiogram.[sup][3] 
 
In​ ​addition,​ ​although​ ​we​ ​agree​ ​that​ ​autoimmune​ ​disease​ ​is​ ​a​ ​multisystem​ ​disease 
usually,​ ​many​ ​autoimmune​ ​diseases​ ​manifest​ ​as​ ​a​ ​single​ ​organ​ ​disease​ ​and​ ​we​ ​clearly 
mentioned​ ​that​ ​the​ ​patient​ ​did​ ​not​ ​have​ ​any​ ​history​ ​or​ ​other​ ​manifestation​ ​of 
autoimmune​ ​disease​ ​besides​ ​Graves'​ ​disease. 
 
LVNC​ ​has​ ​familial​ ​occurrence​ ​rates​ ​of​ ​18%–50%​ ​which​ ​have​ ​been​ ​reported​ ​in​ ​different 
case​ ​series.​ ​It​ ​is​ ​classified​ ​as​ ​an​ ​inherited​ ​genetic​ ​cardiomyopathy​ ​in​ ​50%​ ​of​ ​the​ ​cases 
and​ ​can​ ​be​ ​sporadic​ ​in​ ​other​ ​cases.[sup][4]​ ​Therefore,​ ​our​ ​patient​ ​received​ ​family​ ​and 
genetic​ ​counseling,​ ​and​ ​she​ ​was​ ​advised​ ​that​ ​her​ ​first-degree​ ​family​ ​relatives​ ​need​ ​to 
be​ ​screened​ ​for​ ​LVNC. 
 
However,​ ​there​ ​are​ ​reports​ ​on​ ​association​ ​of​ ​LVNC​ ​with​ ​other​ ​noncardiac​ ​abnormalities 
including​ ​neurological,​ ​facial,​ ​and​ ​hematological.​ ​In​ ​addition,​ ​dermatological​ ​and 
skeletal​ ​anomalies​ ​have​ ​also​ ​been​ ​described​ ​in​ ​isolated​ ​case​ ​reports.[sup][3],[4],[5],[6] 
However,​ ​due​ ​to​ ​the​ ​wide​ ​range​ ​of​ ​noncardiac​ ​abnormalities​ ​associated​ ​with​ ​LVNC​ ​and 
the​ ​rarities​ ​of​ ​these​ ​conditions,​ ​there​ ​are​ ​no​ ​recommendations​ ​to​ ​screen​ ​for​ ​these 
associated​ ​abnormalities​ ​other​ ​than​ ​history​ ​and​ ​physical​ ​examination.​ ​Therefore,​ ​it​ ​is 
not​ ​appropriate​ ​or​ ​necessary​ ​to​ ​perform​ ​an​ ​extensive​ ​diagnostic​ ​workup​ ​in​ ​the​ ​absence 
of​ ​signs​ ​and​ ​symptoms​ ​of​ ​other​ ​organ​ ​involvement.​ ​Our​ ​patient​ ​did​ ​not​ ​have​ ​any 
neurological​ ​or​ ​musculoskeletal​ ​symptoms,​ ​and​ ​her​ ​neurological​ ​examination​ ​was 
normal.​ ​Hence,​ ​it​ ​was​ ​deemed​ ​unnecessarily​ ​to​ ​perform​ ​more​ ​diagnostic​ ​workup​ ​or 
have​ ​her​ ​evaluated​ ​by​ ​a​ ​neurologist. 
 
LVNC​ ​is​ ​a​ ​rare​ ​cardiomyopathy​ ​that​ ​can​ ​rarely​ ​be​ ​asymptomatic​ ​and​ ​manifest​ ​later​ ​in 
life​ ​following​ ​other​ ​unrelated​ ​conditions​ ​that​ ​lead​ ​to​ ​exacerbation​ ​in​ ​contractile 
dysfunction​ ​such​ ​as​ ​Graves'​ ​disease.​ ​Therefore,​ ​increased​ ​awareness​ ​of​ ​this​ ​rare​ ​but 
clinically​ ​significant​ ​cardiomyopathy​ ​is​ ​imperative​ ​for​ ​preventative​ ​and​ ​targeted​ ​therapy 
as​ ​well​ ​as​ ​for​ ​identification​ ​of​ ​potentially​ ​affected​ ​family​ ​members. 
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